{"organizations": [], "uuid": "18701af7b7f4df81013b4651da2561e73e18b5e4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180227.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-dyadic-international-announces-rd/brief-dyadic-international-announces-rd-collaboration-with-mitsubishi-tanabe-pharma-corp-idUSFWN1QH11Q", "country": "US", "domain_rank": 408, "title": "BRIEF-Dyadic International Announces R&D Collaboration With Mitsubishi Tanabe Pharma Corp", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.162, "site_type": "news", "published": "2018-02-27T21:44:00.000+02:00", "replies_count": 0, "uuid": "18701af7b7f4df81013b4651da2561e73e18b5e4"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-dyadic-international-announces-rd/brief-dyadic-international-announces-rd-collaboration-with-mitsubishi-tanabe-pharma-corp-idUSFWN1QH11Q", "ord_in_thread": 0, "title": "BRIEF-Dyadic International Announces R&D Collaboration With Mitsubishi Tanabe Pharma Corp", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "mitsubishi tanabe pharma corp", "sentiment": "negative"}, {"name": "mitsubishi tanabe pharma", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Mitsubishi Tanabe Pharma Corp:\n* ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH MITSUBISHI TANABE PHARMA CORPORATION TO PRODUCE TWO TARGET PROTEINS IN C1\n* ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH MITSUBISHI TANABE PHARMA CORPORATION TO PRODUCE TWO TARGET PROTEINS IN C1 Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T21:44:00.000+02:00", "crawled": "2018-02-28T12:46:56.010+02:00", "highlightTitle": ""}